News | CT Angiography (CTA) | July 03, 2018

HeartFlow Announces New Commercial Coverage With UnitedHealthcare

Decision by largest U.S. insurance provider means HeartFlow Analysis now covered for more than 75 percent of Americans

HeartFlow Announces New Commercial Coverage With UnitedHealthcare

July 3, 2018 — HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45 million beneficiaries. With this new coverage, more than 235 million people in the United States now have access to the HeartFlow Analysis.

The non-invasive technology uses a coronary computed tomography angiogram (CTA) to create a personalized 3-D model of the heart and simulate blood flow in order to help clinicians diagnose and treat people with suspected coronary artery disease (CAD).

In a new coverage decision, UnitedHealthcare also chose to adopt the medical policy for coronary CTA from eviCore, an evidence-based specialty benefits management company. The policy allows for the use of a coronary CTA as a first-line test for symptomatic individuals, removing the need for a standard stress test prior to conducting a coronary CTA. In addition, the HeartFlow Analysis is now approved to further assess coronary disease seen on a coronary CTA that is of uncertain physiological significance.

CAD affects 16.8 million Americans and develops when the coronary arteries narrow, reducing blood flow to the heart and potentially causing chest pain (angina), heart attack (myocardial infarction) and death.

Clinicians diagnosing someone with suspected CAD want to know as definitively as possible if the individual has a significant blockage in their coronary arteries. They also want to know the impact of that blockage on blood flow so they can best determine which treatment pathway is appropriate (e.g., medical management, stenting or coronary artery bypass grafting).

Data from a patient’s non-invasive coronary CTA are securely uploaded from the hospital’s system to the cloud. HeartFlow leverages deep learning to create a personalized, digital 3-D model of the patient’s coronary arteries. The HeartFlow Analysis then uses powerful computer algorithms to solve millions of complex equations to simulate blood flow and assess the impact of blockages on coronary blood flow. The service is provided via a secure online interface to offer actionable information to enable clinicians to determine the optimal course of treatment.

For more information: www.heartflow.com


Related Content

News | Angiography

January 31, 2024 — Coronary artery calcification is increasing in prevalence, leading to greater risks both during ...

Home January 31, 2024
Home
Feature | Angiography | By Bhvita Jani

The world market for interventional X-ray and mobile C-arm equipment is forecast to reach over $4.9 billion by 2026 ...

Home November 09, 2022
Home
News | Angiography
April 6, 2022 – According to ARRS’ American Journal of Roentgenology (AJR), the 3-T Dixon gradient-recalled echo (GRE) ...
Home April 06, 2022
Home
News | Angiography

April 7, 2021 — Philips Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its Philips ...

Home April 07, 2021
Home
Feature | Angiography | By Bhvita Jani

January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve ...

Home January 19, 2021
Home
News | Angiography

December 3, 2020 — GE Healthcare is introducing a new version of its robotic driven angiography system for image guided ...

Home December 01, 2020
Home
Feature | Angiography | Dave Fornell, Editor

Philips is working on a prototype cath lab angiographic imaging system that might be able to replace the current X-ray ...

Home March 12, 2020
Home
News | Angiography

February 12, 2020 — The University of Wisconsin (UW) Health’s University Hospital in Madison, Wis., recently became the ...

Home February 12, 2020
Home
News | Angiography

October 9, 2019 — In the complex and fast-paced world of healthcare, customers face the challenge of staying up-to-date ...

Home October 09, 2019
Home
Technology | Angiography

September 17, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of ...

Home September 17, 2019
Home
Subscribe Now